Overview
- Editors:
-
-
Peter M. Schlag
-
Robert-Rössle-Hospital and Tumor Institute, Charité University of Medicine, Berlin
Max-Delbrück-Center for Molecular Medicine, Berlin, Germany
-
Ulrike Stein
-
Max-Delbrück-Center for Molecular Medicine, Berlin, Germany
Tumor Metastasis and Therapy Response Program, Robert-Rössle-Hospital and Tumor Institute, Charité University of Medicine, Berlin
-
Alexander M. M. Eggermont
-
Erasmus University MC—Daniel den Hoed Cancer Center, Rotterdam, The Netherlands
- Biological and pharmacological backgrounds for regional cancer therapy
- Techniques and prerequisites for regional cancer therapy
- Indications and results for several different tumor entities
- Regional therapy of pancreatic, rectal, breast, ovarian, bladder, and brain tumors
Access this book
Other ways to access
Table of contents (27 chapters)
-
-
Background
-
-
- Ulrike S. Stein, Wolfgang Walther, Peter M. Schlag
Pages 3-18
-
- Hans Gelderblom, Joost Rothbarth, Cornelius J. H. van de Velde, Henk-Jan Guchelaar
Pages 19-28
-
- Timo L. M. ten Hagen, Alexander M. M. Eggermont
Pages 29-44
-
Techniques and Prerequisites for Regional Therapy
-
-
- Enrique Lopez Hänninen, Timm Denecke
Pages 47-58
-
- Sandra Grünberg, Peter M. Schlag
Pages 59-72
-
- Peter Wust, Johanna Gellermann
Pages 73-90
-
- Eren Berber, Allan E. Siperstein
Pages 91-100
-
- Tristan D. Yan, Faruque Riffat, David L. Morris
Pages 101-115
-
-
- Robert F. Wong, Amanjit S. Gill, Manoop S. Bhutani
Pages 133-162
-
-
- Wolfgang Walther, Ulrike S. Stein, Peter M. Schlag
Pages 181-196
-
Indications and Results for Different Tumor Entities
-
Front Matter
Pages 197-197
-
- Rebecca Taylor, James Tomlinson, Nancy Kemeny
Pages 199-228
-
- Giuseppe Garcea, David P. Berry
Pages 229-267
-
- Yehuda Skornick, Paul H. Sugarbaker
Pages 269-282
-
- David P. Mangiameli, Steven K. Libutti, James F. Pingpank, H. Richard Alexander
Pages 283-302
About this book
Regional cancer therapies remain important options in the management of malignant disease, in spite of the venue of more targeted agents for systemic therapies. New te- nologies and better guidance systems for radiofrequency ablation and intrastitial laser therapies, highly selective intravascular approaches with improved catheters and gu- ance systems, improved agents for embolizations, and new vasoactive drugs for isolated limb and liver perfusions are just a few of the new developments in a field that is alive and progressing. Regional Cancer Therapy, so well put together by the editors Peter M. Schlag and Ulrike S. Stein, presents an overview of today’s realities and tomorrow’s possibilities. Regional cancer therapy models provide ways to make new discoveries about tumor biology and new agents that may be used regionally as well as systemically. This book should therefore be of interest to all clinicians and scientists with an interest in tumor biology as well as clinical advances. Alexander M. M. Eggermont, MD, PhD Professor and Head of Surgical Oncology Erasmus University MC—Daniel den Hoed Cancer Center Rotterdam, the Netherlands v PREFACE The treatment of malignant tumors has been substantially improved in recent years due to developments in clinical medicine and technology as well as by advances in mole- lar biological research. Modern molecular and genetic techniques allow the charact- ization of molecules that are decisive for tumor development and progression.
